HR.3473 - Qualifying Therapeutic Discovery Project Tax Credit Extension Act Of 2013

Send your vote to Congress

My Vote

{{ my_vote|capitalize }}

My Vote

{{ bill_vote.meta.gov_vote|capitalize }}

Congress Vote

{{ bill_vote.meta.user_vote|capitalize }}

People's Vote

{{ bill_vote.meta.outcome|capitalize }}


11/13/2013--Introduced. Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to make permanent the authority to invest in and allocate credit amounts for a qualifying therapeutic discovery project (a project that is designed to: (1) treat or prevent diseases by conducting pre-clinical activities, clinical trials, and clinical studies or by carrying out research projects to approve new drugs or other biologic products; (2) diagnose diseases or conditions to determine molecular factors related to diseases or conditions; or (3) develop a product, process, or technology to further the delivery or administration of therapeutics). Extends the $1 billion allocation for such credit for each 2-year period beginning after 2013 and provides for a biennial inflation adjustment to such allocation amount after 2015.

Referred To The House Committee On Ways And Means.
November 13th 2013 @ 12:00 AM

VoteTocracy Voting & Activity
Votetocracy user
{{ error }}
Votetocracy user
{{ activity.user }} in {{ activity.state }} Voted on Bill {{ activity.bill_id|billName }} {{ activity.when|howLongAgo }} Reply
{{ error }}
Govtrack Data provided by Bill analysis provided by’s analyst team.